| Target | |
|---|---|
| Description | Monoclonal Cell Line Derived from K562 Cells, Engineered for Stable Expression of Human FZD10 Using Lentiviral Technology |
| Host Cells | K562 |
| Uniprot ID | Q9ULW2 |
| Applications | FACS Data |
| Growth media | RPMI-1640+10% FBS+1% P.S+1% Gln+2 ug/mL Puromycin |
| Package | 5E6 Cells/mL |
| Host Species | Human |
| Suggested Control | SKU: BME100185 |
| Warranty and Disclaimer | 1. Please inspect cells upon receipt and report any issues promptly. 2. We offer one-time replacements for issues reported within a week of receipt. 3. User-induced issues are not eligible for free replacements. 4. We do not accept liability for damages resulting from cell use, storage, or loss. 5. Feedback received more than one month after receipt will not be processed. |
| Storage & Shipping | Cells are shipped using dry ice and require liquid nitrogen storage for long term preservation. |
| Synonyms | CD350; FZ-10; Fz10; FzE7; hFz10 |
| Background | This gene is a member of the frizzled gene family. Members of this family encode 7-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. Using array analysis; expression of this intronless gene is significantly up-regulated in two cases of primary colon cancer. [provided by RefSeq; Jul 2008] |
| Usage | For research use only. |
Hu_FZD10 K562 Cell Line
Price:Inquiry
Product Data
Images
Figure 1. Flow cytometry analysis of human FZD10 overexpression using Hu_FZD10 K562 Cell Line (Cat. No. CEL100053) and Anti-FZD10(tabituximab biosimilar) mAb (Cat. No. BME100185)